Literature DB >> 179860

Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas.

N Prajda, G Weber.   

Abstract

Xanthine oxidase was decreased 2- to 10-fold in all examined rat hepatomas irrespective of the malignancy; growth rate and degrees of histological differentiation of the neoplasms. The affinity to substrate (KM=6-8 muM) and the pH optimum (8.0) of the liver and hepatoma enzymes were the same. The reprogramming of gene expression, as manifested in the decreased activity of this key purine metabolizing enzyme, appears to be specific to neoplastic transformation. Since glutamine PRPP amidotransferase activity was increased but the opposing enzyme, xanthine oxidase, was decreased in all the hepatomas, the reprogramming of gene expression results in an imbalance that favors synthesis against catabolism. This enzymatic imbalance should confer selective advantages to the cancer cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 179860     DOI: 10.1016/0014-5793(75)80385-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  63 in total

1.  Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection.

Authors:  Chun-Che Lin; Wen-Hu Liu; Zhi-Hong Wang; Mei-Chin Yin
Journal:  Eur J Nutr       Date:  2010-12-24       Impact factor: 5.614

2.  The effects of chronic exposure to ethanol and cigarette smoke on the formation of peroxynitrite, level of nitric oxide, xanthine oxidase and myeloperoxidase activities in rat kidney.

Authors:  Yilmaz Cigremis; Yusuf Turkoz; Mehmet Tuzcu; Hasan Ozen; Asim Kart; Muhammet Gaffaroglu; Kenan Erdogan; Muslum Akgoz; Fikret Ozugurlu
Journal:  Mol Cell Biochem       Date:  2006-06-07       Impact factor: 3.396

3.  The protective effect of erdosteine against ototoxicity induced by cisplatin in rats.

Authors:  M Tayyar Kalcioglu; Ahmet Kizilay; Mukaddes Gulec; Erkan Karatas; Mustafa Iraz; Omer Akyol; Mucahit Egri; Orhan Ozturan
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-02       Impact factor: 2.503

4.  Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats.

Authors:  Ozkan Ates; Neslihan Yucel; Suleyman R Cayli; Eyup Altinoz; Saim Yologlu; Ayhan Kocak; Celal Ozbek Cakir; Yusuf Turkoz
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

5.  B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer.

Authors:  Chun-che Lin; Mei-chin Yin
Journal:  Eur J Nutr       Date:  2007-06-14       Impact factor: 5.614

6.  Cigarette smoke and bleomycin-induced pulmonary oxidative stress in rats.

Authors:  Turgut Teke; Emin Maden; Aysel Kiyici; Celalettin Korkmaz; Mehmet Gok; Faruk Ozer; Oktay Imecik; Kursat Uzun1
Journal:  Exp Ther Med       Date:  2012-04-17       Impact factor: 2.447

7.  The role of allopurinol on oxidative stress in experimental hyperthyroidism.

Authors:  O Makay; C Yenisey; G Icoz; N Genc Simsek; G Ozgen; M Akyildiz; E Yetkin
Journal:  J Endocrinol Invest       Date:  2009-09       Impact factor: 4.256

8.  A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles.

Authors:  Ebru Celik; Onder Celik; Banu Kumbak; Ercan Yilmaz; Ilgin Turkcuoglu; Yavuz Simsek; Abdullah Karaer; Yagmur Minareci; Elif Ozerol; Kevser Tanbek
Journal:  J Assist Reprod Genet       Date:  2012-08-12       Impact factor: 3.412

9.  Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology.

Authors:  Lambert C M Ngoka
Journal:  Proteome Sci       Date:  2008-10-24       Impact factor: 2.480

10.  Orange juice and hesperetin supplementation to hyperuricemic rats alter oxidative stress markers and xanthine oxidoreductase activity.

Authors:  Fatemeh Haidari; Seid Ali Keshavarz; Mohammad Reza Rashidi; Majid Mohammad Shahi
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.